Robin Shane Readnour

ANTX

Robin Shane Readnour serves as director at AN2 Therapeutics, Inc. (ANTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

4 trades

$2.65M

Total Sells

5 trades

$428.4K

Net Position

Net Buyer

$2.22M

Companies Traded

ANTX

Active Period

Mar 2022 – Sep 2026

9 total trades

Most Recent

Sell ANTX

Sep 11, 2026 · $6.7K

Robin Shane Readnour's Insider Trading at AN2 Therapeutics, Inc. (ANTX)

Buys

4 · $2.65M

Sells

5 · $428.4K

Total Shares Bought

445,834

Total Shares Sold

57,723

ANTX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 11, 2026	Sell	1,108	$6.02	$6.7K	624,765
Sep 8, 2026	Sell	16,119	$6.04	$97.3K	630,644
Aug 19, 2026	Sell	35,402	$6.01	$212.7K	633,867
Dec 6, 2024	Buy	55,000	$1.44	$79.2K	0
Nov 26, 2024	Buy	37,500	$1.41	$52.8K	0
Nov 19, 2024	Buy	200,000	$1.07	$213.1K	0
Jan 12, 2024	Sell	1,425	$21.91	$31.2K	0
Jan 10, 2024	Sell	3,669	$21.93	$80.4K	0
Mar 29, 2022	Buy	153,334	$15.00	$2.30M	0